CannaPharmaRX, Inc. (CPMD)
OTCMKTS · Delayed Price · Currency is USD
0.0042
+0.0011 (35.48%)
Jan 20, 2026, 3:44 PM EST
CannaPharmaRX Revenue
CannaPharmaRX had revenue of $656.61K in the quarter ending September 30, 2025, with 110.34% growth. This brings the company's revenue in the last twelve months to $1.71M, up 404.63% year-over-year. In the year 2024, CannaPharmaRX had annual revenue of $820.14K.
Revenue (ttm)
1.71M
Revenue Growth
+404.63%
P/S Ratio
1.62
Revenue / Employee
65.60K
Employees
26
Market Cap
2.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 820.14K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Vaxart | 148.20M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Stem Cell Authority | 3.33M |
CannaPharmaRX News
- 8 days ago - CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026 - Accesswire
- 5 months ago - CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue - Accesswire
- 9 months ago - CannapharmaRx Continues into New European Market with First Shipment Completed to Germany - Accesswire
- 1 year ago - CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy - Accesswire
- 1 year ago - CannapharmaRx to Complete Additional Shipment in November - Accesswire
- 1 year ago - CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product - Accesswire
- 1 year ago - Q1 2024 Financial Results - Accesswire
- 1 year ago - CannapharmaRx Pays Off Convertible Notes - Accesswire